Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Oliver Daumke0
Felix Oden0
Stephen Marino0
Date of Patent
December 4, 2018
0Patent Application Number
153064380
Date Filed
April 30, 2015
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention relates to humanized antibodies or antibody fragments that bind CD269 (BCMA), thereby disrupting the interaction between CD269 and its native ligands (BAFF and APRIL), and their use in the treatment of plasma cell-mediated diseases such as multiple myeloma and autoimmune diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
